Nothing Special   »   [go: up one dir, main page]

IL133144A0 - Vaccine compositions comprising the helicobacter pylori flge polypeptide - Google Patents

Vaccine compositions comprising the helicobacter pylori flge polypeptide

Info

Publication number
IL133144A0
IL133144A0 IL13314498A IL13314498A IL133144A0 IL 133144 A0 IL133144 A0 IL 133144A0 IL 13314498 A IL13314498 A IL 13314498A IL 13314498 A IL13314498 A IL 13314498A IL 133144 A0 IL133144 A0 IL 133144A0
Authority
IL
Israel
Prior art keywords
helicobacter pylori
vaccine compositions
flge polypeptide
pylori flge
polypeptide
Prior art date
Application number
IL13314498A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL133144A0 publication Critical patent/IL133144A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13314498A 1997-06-12 1998-06-08 Vaccine compositions comprising the helicobacter pylori flge polypeptide IL133144A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (1)

Publication Number Publication Date
IL133144A0 true IL133144A0 (en) 2001-03-19

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13314498A IL133144A0 (en) 1997-06-12 1998-06-08 Vaccine compositions comprising the helicobacter pylori flge polypeptide

Country Status (21)

Country Link
EP (1) EP1009764A1 (xx)
JP (1) JP2002507118A (xx)
KR (1) KR20010013699A (xx)
CN (1) CN1259960A (xx)
AR (1) AR012896A1 (xx)
AU (1) AU8048798A (xx)
BR (1) BR9810026A (xx)
CA (1) CA2293293A1 (xx)
EE (1) EE9900566A (xx)
HU (1) HUP0003164A3 (xx)
ID (1) ID23052A (xx)
IL (1) IL133144A0 (xx)
IS (1) IS5288A (xx)
NO (1) NO996132L (xx)
NZ (1) NZ501427A (xx)
PL (1) PL337503A1 (xx)
SE (1) SE9702242D0 (xx)
SK (1) SK173099A3 (xx)
TR (1) TR199903060T2 (xx)
WO (1) WO1998056816A1 (xx)
ZA (1) ZA984696B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (zh) * 2015-04-27 2015-07-22 苏州大学附属第一医院 重组绿脓杆菌鞭毛钩蛋白FlgE的用途
CN113425717B (zh) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用
CN116535472B (zh) * 2023-05-31 2024-04-30 四川大学华西医院 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用
CN118105473B (zh) * 2024-04-30 2024-08-16 成都欧林生物科技股份有限公司 一种预防或治疗Hp感染口服免疫原性组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la

Also Published As

Publication number Publication date
NO996132L (no) 2000-01-28
BR9810026A (pt) 2000-09-19
JP2002507118A (ja) 2002-03-05
NO996132D0 (no) 1999-12-10
WO1998056816A1 (en) 1998-12-17
EP1009764A1 (en) 2000-06-21
AU8048798A (en) 1998-12-30
PL337503A1 (en) 2000-08-28
CA2293293A1 (en) 1998-12-17
IS5288A (is) 1999-12-08
CN1259960A (zh) 2000-07-12
ID23052A (id) 2000-01-20
HUP0003164A2 (hu) 2000-12-28
ZA984696B (en) 1999-01-04
HUP0003164A3 (en) 2001-10-29
TR199903060T2 (xx) 2000-09-21
EE9900566A (xx) 2000-06-15
SE9702242D0 (sv) 1997-06-12
SK173099A3 (en) 2000-06-12
AR012896A1 (es) 2000-11-22
KR20010013699A (ko) 2001-02-26
NZ501427A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
PL337488A1 (en) Oil-in-water type compositions for vaccines
HUP9901546A3 (en) Helicobacter pylori antigens and vaccine compositions
ZA978868B (en) Vaccine composition
AU8005098A (en) Alpha1,3-fucosyltransferase of helicobacter pylori
HK1039068A1 (en) Antigenic peptides derived from telomerase
ZA976815B (en) Vaccine composition.
ZA979984B (en) Vaccine composition
EP0998942A4 (en) METHOD FOR STABILIZING PEPTIDES AND FREEZERED MEDICINAL COMPOSITIONS THEREOF
HU9600207D0 (en) Vaccine compositions
AU1698699A (en) (helicobacter pylori) vaccine formulations
HUP0003164A3 (en) Vaccine compositions comprising the helicobacter pylori flge polypeptide
HK1026626A1 (en) Immunopotentiating formulations for vaccinal use.
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
AU7945798A (en) Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide
GB9413073D0 (en) Helicobacter pylori vaccines/therapeutic compositions
GB9614618D0 (en) Vaccine compositions
ZA98588B (en) H. Pylori antigens.
ZA972566B (en) Polysorbate-containing compositions and their use against Helicobacter.
AU4789400A (en) (helicobacter pylori) antigens
GB9705460D0 (en) Polynucleotide vaccine formulations
GB9714333D0 (en) Rotavirus vaccine formulations
GB9622439D0 (en) Vaccine composition
ZA978586B (en) Rotavirus vaccine formulations.
GB9621991D0 (en) Rotavirus vaccine formulations
AUPO589497A0 (en) Novel helicobacter antigens